Abstract:Background The majority of patients with angina and non-obstructive coronary arteries (ANOCA) are women. In most of these patients coronary vasomotor dysfunction, consisting of coronary vasospasm and coronary microvascular dysfunction (CMD), are identified through invasive coronary function testing (CFT). To acknowledge possible sex differences in clinical characteristics and in the entities of coronary vasomotor dysfunction more data are needed. Therefore, this study presents data from one centre participating in the Dutch national CFT (NL-CFT) registry in order to investigate sex differences in patients with a clinical indication for CFT. Methods This retrospective cohort study included 285 consecutive ANOCA patients undergoing clinically indicated CFT, using the Doppler wire or the bolus thermodilution method, from November 2016 till June 2023. CFT consisted of incremental doses of intracoronary acetylcholine (ACh) for the diagnosis of coronary vasospasm and intracoronary adenosine for the diagnosis of CMD defined as abnormal coronary flow reserve (CFR) and/or microvascular resistance (MR). Results In total, 285 patients of which 233 (82%) women and 52 (18%) men were included. Women were significantly younger (56 vs 59 yrs.; p=0.046), had less diabetes (6% vs 23% p<0.001), less prior PCI (12% vs 27%; p=0.019) and less statin use (39% vs 60%; p=0.006), and more often migraine at some point in their life (38% vs 9%; p<0.001). The prevalence of coronary vasomotor dysfunction (77% vs 65%, p=0.086), epicardial spasm (26% vs 31%, p=0.500), microvascular spasm (35% vs 23%, p=0.104), and CMD (35% vs 27%, p=0.304), was not significantly different between women and men. However, a trend was seen towards a higher prevalence of coronary vasomotor dysfunction, microvascular spasm and CMD in women. In total, 29% of women had an abnormal CFR compared to 16% of men (p=0.065) and an abnormal MR was seen in 11% of women and 12% of men (p=0.938). Cardiovascular risk factors were similar between women and men with epicardial spasm. In patients with microvascular spasm women had less prior PCI (p=0.025) and more migraine (p=0.005), in CMD patients women had less diabetes (p=0.002) and hypercholesterolemia (p=0.044) and more migraine (p=0.006). Conclusion In the NL-CFT registry study including ANOCA patients with a clinical indication for CFT women were younger, had less prior PCI and, diabetes and more often migraine. A trend towards a higher prevalence of coronary vasomotor dysfunction, microvascular spasm and CMD was found in women. Furthermore, our results suggest that men with CMD or microvascular spasm have a different cardiovascular risk profile compared to women, which might suggest different optimal tailored treatment for men compared to women. * Upon acceptance for presentation at the ESC Congress, all patients from the Dutch NL-CFT registry will be incorporated into this analysis, resulting in a study population of approximately 1200 individuals.

The Influence of Sex and Gender on the Level and Course of Subjective Cognitive Complaints After Percutaneous Coronary Intervention

The role of sex and gender in somatic complaints among patients with coronary heart disease: A longitudinal study on acute and long-term changes

[Psychologic Status and Their Influencing Factors in Patients Suspected of Coronary Disease Before and after Coronary Catheterization].

Sex Differences in Depression, Anxiety, Stress, and Mindfulness Among Patients With Percutaneous Coronary Intervention

Perceived Cognition after Percutaneous Coronary Intervention: Association with Quality of Life, Mood and Fatigue in the THORESCI Study

Chronic stress exposure in men and women, and implications for the course of fatigue after percutaneous coronary intervention; the THORESCI study

Impact of Sex on Clinical Outcomes in Patients undergoing Complex Percutaneous Coronary Angioplasty (from the e-ULTIMASTER Study)

Sex Differences in Delirium after Coronary Artery Bypass Graft Surgery and Perioperative Neuropsychiatric Conditions: A Secondary Analysis of a Cohort Study

Post-COVID-19 illness and associations with sex and gender

Persistent sex differences in outcomes after coronary heart disease: time to move from observation to action

Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial

Sex related disparities after complex percutaneous coronary interventions

Patient-Reported Postoperative Neuropsychological Deterioration After Heart Valve Replacement and Coronary Artery Bypass Grafting

Anxiety in patients undergoing percutaneous coronary interventions

Women With Cerebral Infarction Feature Worse Clinical Profiles at Admission but Comparable Success to Men During Long-Term Inpatient Neurorehabilitation

Sex Differences in Long-Term Outcomes in Patients With Chronic Coronary Syndrome After Percutaneous Coronary Intervention - Insights From a Japanese Real-World Database Using a Storage System

Sex-based influence on clinical outcomes after drug-eluting stent implantation in real-world patients: insight from the FOCUS registry.

Sex Differences in Demographics, Risk Factors, Presentation, and Noninvasive Testing in Stable Outpatients With Suspected Coronary Artery Disease: Insights From the PROMISE Trial

Gender bias in cardiovascular testing persists after adjustment for presenting characteristics and cardiac risk

Sex-differences in ANOCA patients undergoing invasive coronary function testing: preliminary results from the Dutch national NL-CFT registry

Sex Differences in Symptom Phenotypes Among Patients With Acute Myocardial Infarction